REBECCA GUICE: Open Payments
NPI 1811445414 · GAUTIER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 129 payments from 19 companies in 2025. Trend: 2023 $1,258 · 2024 $1,876 · 2025 $2,455
Food & beverage: $2,363Education: $92
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $369 |
| UCB, Inc. | 18 | $351 |
| Galderma Laboratories, L.P. | 13 | $223 |
| Regeneron Healthcare Solutions, Inc. | 9 | $216 |
| GENZYME CORPORATION | 16 | $178 |
| Janssen Biotech, Inc. | 12 | $162 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| Organon LLC | 5 | $124 |
| LEO Pharma Inc. | 4 | $120 |
| PFIZER INC. | 5 | $104 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, TREMFYA, RINVOQ, CIBINQO, Sotyktu.
Industry payments across MS — which companies pay providers there.
